netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,0)
04.01.01 Hypnotics (2,0)
Benzodiazepines (0,3)
Zaleplon, Zolpidem and Zopiclone (1,4)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (3,3)
04.01.03 Barbiturates (0,4)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (3,20)
Second-Generation Antipsychotic Drugs (8,6)
04.02.02 Antipsychotic depot injections (7,3)
04.02.03 Drugs used for mania and hypomania (0,1)
Valproic acid (1,0)
Lithium (2,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (4,9)
04.03.02 Monoamine-oxidase inhibitors (0,3)
04.03.03 Selective serotonin re-uptake inhibitors (7,5)
04.03.04 Other antidepressant drugs (5,12)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (4,3)
04.05 Drugs used in the treatment of obesity (1,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestingal tract (1,0)
04.05.02 Centrally acting appetite suppressants (0,3)
04.06 Drugs used in nausea and vertigo (0,0)
Antihistamines (2,5)
Phenothiazines and related drugs (2,5)
Domperidone and metoclopramide (2,4)
5HT3 antagonists (2,5)
Neurokinin receptor antagonist (1,1)
Other drugs for Ménière's disease (1,1)
04.07 Analgesics (2,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
Compound analgesic preparations (2,17)
04.07.02 Opioid analgesics (10,34)
04.07.03 Neuropathic pain (5,1)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (4,2)
5HT1 agonists (3,5)
04.07.04.02 Prophylaxis of migraine (7,5)
04.07.04.03 Cluster headache (0,0)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (3,0)
Carbamazepine and Oxcarbazepine (3,0)
Ethosuximide (1,1)
Gabapentin and pregabalin (2,0)
Lamotrigine (1,1)
Levetiracetam (1,0)
Phenytoin (1,1)
Tiagabine (1,0)
Topiramate (1,0)
Valproate (1,1)
Vigabatrin (1,0)
Zonisamide (1,0)
Other Drugs (3,1)
04.08.02 Drugs used in status epilepticus (3,4)
04.08.03 Febrile convulsions (0,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (3,1)
Dopamine receptor agonists (4,5)
Levodopa (2,6)
Monoamine-oxidase-B inhibitors (1,3)
Catachol-O-methyltransferase inhibitors (1,1)
04.09.02 Antimuscarinic drugs used in parkinsonism (1,8)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (1,4)
04.10 Drugs used in substance dependence (0,0)
04.10.01 Alcohol dependence (2,2)
04.10.02 Nicotine dependence (3,0)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (3,0)
Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (5,2)
04.12 Drugs for sialorrhoea (1,0)
netFormulary